Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xiaoshuan enteric coated capsules for post-cardiovascular/cerebrovascular event fatigue syndrome
ChiCTR2400089590Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Dalian Medical University
- Start
- Sep 2024
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of Xiaoshuan enteric-coated capsules in myalgic encephalomyelitis (ME) (2 arms), sponsored by The First Affiliated Hospital of Dalian Medical University. Primary endpoints: 90-day FAI fatigue scale score, 90-day Qi Deficiency Scale score and 1 more. Planned start Sep 2024; status: not yet recruiting.
02
Drugs
Xiaoshuan enteric-coated capsules
03
Conditions
myalgic encephalomyelitis (ME)
Beyond the preview
Go deeper on ChiCTR2400089590.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400089590.